Jake Shortt
research.monash.edu
0000-0003-3185-6488
MONASH UNIVERSITY
2 papers found
Refreshing results…
Sequential high‐dose methotrexate and cytarabine administration improves outcomes in real‐world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance
Excellent outcomes in older patients with primary CNS lymphoma treated with R-MPV/cytarabine without whole brain radiotherapy or autologous stem cell transplantation therapy
Missing publications? Search for publications with a matching author name.